UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028721
Receipt number R000032870
Scientific Title Study of intestinal bacterial flora of H. pylori-infected person and non-infected person and relation with basic disease
Date of disclosure of the study information 2017/08/18
Last modified on 2019/08/24 11:41:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of intestinal bacterial flora of H. pylori-infected person and non-infected person and relation with basic disease

Acronym

Study of intestinal bacterial flora with or without H.pylori infection

Scientific Title

Study of intestinal bacterial flora of H. pylori-infected person and non-infected person and relation with basic disease

Scientific Title:Acronym

Study of intestinal bacterial flora with or without H.pylori infection

Region

Japan


Condition

Condition

Helicobacter pylori infection

Classification by specialty

Gastroenterology Child

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To analyze fecal matter of people infected with Helicobacter pylori infection (before eradication treatment) in third grade junior high school students in Saga prefecture and feces of uninfected persons, and investigate the difference between the microbial flora and the relation with each underlying disease.

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Relationship between H. pylori infection and intestinal flora
Relationship between H. pylori infection and underlying disease

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Among the middle school third grader in Saga prefecture, we define that negative groups are negative in urinary anti-H. pylori infection examination. For fecal specimens provided by these subjects, a comprehensive analysis of the intestinal microflora is performed using the next generation sequencer.

Interventions/Control_2

Among the middle school third grader in Saga prefecture, we define that positive groups are positive for primary examination and also positive for H. pylori antigen test in feces. For fecal specimens provided by these subjects, a comprehensive analysis of the intestinal microflora is performed using the next generation sequencer.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

16 years-old >

Gender

Male and Female

Key inclusion criteria

Urinary anti-H. pylori antibody test recipient In Saga Prefecture's commissioned project "Promotion of Stomach Cancer Measures for the Future"

Key exclusion criteria

1. Persons who were unable to obtain consent from the person or guardian
2. Person who is responsible for research, and who is in the hospital, judged that the attending physician has problems in participation
3. Those who have already taken H. pylori eradication treatment

Target sample size

160


Research contact person

Name of lead principal investigator

1st name Muneaki
Middle name
Last name Matsuo

Organization

Saga University Hospital

Division name

Pediatrics

Zip code

849-8501

Address

5-1-1 Nabeshima saga-Cuty 849-8501 Japan

TEL

0952342314

Email

matsuo@cc.saga-u.ac.jp


Public contact

Name of contact person

1st name Shinya
Middle name
Last name Kimura

Organization

Saga University Hospital

Division name

Pediatrics

Zip code

849-8501

Address

5-1-1 Nabeshima saga-Cuty 849-8501 Japan

TEL

0952342314

Homepage URL


Email

kakiucht@cc.saga-u.ac.jp


Sponsor or person

Institute

Saga University

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Biofermin Seiyaku Co., Ltd.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Division of Clinical Research Center, Saga University

Address

5-1-1 Nabeshima, Saga, 849-8501 Japan

Tel

0952-34-3400

Email

kenkyu-shinsei@ml.cc.saga-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 08 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

149

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 03 Month 23 Day

Date of IRB

2017 Year 03 Month 23 Day

Anticipated trial start date

2017 Year 03 Month 23 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry

2019 Year 03 Month 31 Day

Date trial data considered complete

2019 Year 03 Month 31 Day

Date analysis concluded

2019 Year 07 Month 31 Day


Other

Other related information

Distribute the personal information confirmation slip at the time of submitting the fecal specimen for intestinal bacterial flora and receive information. The contents include the name, date of birth, parental name, address, telephone number, name of the disease being diagnosed, current internal medicine, nutrition at infancy, presence or absence of collective childcare before preschool, family composition.


Management information

Registered date

2017 Year 08 Month 18 Day

Last modified on

2019 Year 08 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032870